Latest news releases from PR.com for GTCbio. http://www.pr.com/press-releases Sun, 12 Oct 2008 20:49:04 -0500 http://www.pr.com/images/logo_white.jpg http://www.pr.com/ 68 69 PR.com provides Free Press Release Distribution, & is a unique Directory of Businesses, Products, Services, & Jobs - in all industries. Find Full Company Profiles. © 2008 PR Worldwide, Inc. 60 http://www.pr.com/press-release/101715 Dr. Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono International in Geneva, Switzerland will present at the Plenary Keynote session at GTCbio’s 4th Modern Drug Discovery and Development Summit on October 15-17, 2008 at the Hilton La Jolla Torrey Pines in La Jolla, CA. Dr. Luthman’s presentation entitled “Small Pharma, Big Pharma and Small Drugs and Big Drugs; Or Middle Way [PR.com - August 23, 2008] GTCbio http://www.pr.com/press-release/101715 http://www.pr.com/press-release/101291 Dr. Stanley Deresinski, Clinical Professor of Medicine-Med/Infectious Diseases at Stanford University in Palo Alto, CA will speak on “The Seemingly Never-ending Promise of Bacteriophage Therapy: Exploiting Smaller Fleas” at GTCbio’s Bugs & Drug Conf. on Sept. 22-23, 2008 at the DoubleTree Club Hotel in San Diego, CA. Dr. Deresinski will speak on the renewed interest in Phage Therapy. Administration [PR.com - August 21, 2008] GTCbio http://www.pr.com/press-release/101291 http://www.pr.com/press-release/101289 Sharath Hegde, Vice President of Pharmacology at Theravance, Inc. in South San Francisco, CA will speak on “Telavancin: A Novel Lipoglycopeptide Gram-Positive Antibiotic” at GTCbio’s Bugs & Drug Conference on September 22-23, 2008 at the DoubleTree Club Hotel in San Diego, CA. Telavancin (TLV) is an investigational lipoglycopeptide antibiotic that has broad-spectrum activity against Gram-positive [PR.com - August 21, 2008] GTCbio http://www.pr.com/press-release/101289 http://www.pr.com/press-release/101287 Dr. Rita Helfand, Associate Director of Epidemiologic Science at the National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention will speak on “Controlling Infectious Diseases: Progress and Challenges in Addressing Known and Unknown Threats” at GTCbio’s Bugs & Drug Conference on September 22-23, 2008 at the DoubleTree Club Hotel in San [PR.com - August 21, 2008] GTCbio http://www.pr.com/press-release/101287 http://www.pr.com/press-release/101286 Dr. Barry Eisenstein, Senior Vice President of Scientific Affairs at Cubist Pharmaceuticals in Lexington, MA and Clinical Professor of Medicine, Harvard Medical School in Cambridge, MA gives the keynote address on getting congress to understand the need for antibiotic development. In contrast to the discovery and development of other therapeutic areas, antimicrobials, and specifically anti-bacterial agents, have unique [PR.com - August 21, 2008] GTCbio http://www.pr.com/press-release/101286 http://www.pr.com/press-release/99545 Dr. Ashraf Hanna, Vice President of Alliance Management and Portfolio Planning at Genentech in San Francisco, CA will present at the Plenary Keynote session at GTCbio’s 4th Modern Drug Discovery and Development Summit on October 15-17, 2008 in La Jolla, CA. Dr. Hanna will present on The Cost and Benefit of Portfolio Innovation. In his presentation, Dr. Hanna will review historical drug development costs and its [PR.com - August 09, 2008] GTCbio http://www.pr.com/press-release/99545 http://www.pr.com/press-release/99544 GTCbio just announced the commencement of its inaugural conference on Global Clinical Trial Operations taking place on September 25-26, 2008 in San Diego, CA. Outsourcing to CROs has proven to be much more cost effective and less time consuming when conducting clinical trials. The steps to ensuring a successful trial are long and crucial to the approval of a drug. Companies must consider many aspects of a clinical trial [PR.com - August 09, 2008] GTCbio http://www.pr.com/press-release/99544 http://www.pr.com/press-release/99543 GTCbio just announced the 3rd edition of its Biomarker Series – the Biomarker Discovery Europe Conference - taking place on October 2-3, 2008 in Dublin, Ireland. Over the last several years, biomarkers have been an increasingly important and a heavily researched topic at all of the leading pharmaceutical and biotech companies worldwide. There have been many new advancements in the technologies used to facilitate [PR.com - August 09, 2008] GTCbio http://www.pr.com/press-release/99543 http://www.pr.com/press-release/99539 GTCbio just announced its inaugural Bugs & Drugs conference – one of the leading forums to address unmet medical needs for problematic microbials - taking place on September 22-23, 2008 in San Diego, CA. Infections are becoming increasingly problematic due to the recent resistances to current antibiotics. Patients suffering from resistant bugs (hospital-acquired or community-acquired) now need new yet [PR.com - August 09, 2008] GTCbio http://www.pr.com/press-release/99539 http://www.pr.com/press-release/99541 GTCbio just announced the scheduling of its 4th annual Neurodegenerative Diseases Drug Discovery Conference on October 9-10, 2008 in Philadelphia, PA. Neurodegenerative diseases continue to play an enormous role in the growing public health problem, disrupting the quality of life of millions of people and costing society billions of dollars annually. Nonetheless, in the last few years, there has been great progress in [PR.com - August 09, 2008] GTCbio http://www.pr.com/press-release/99541 http://www.pr.com/press-release/95748 Dr. Robert J. Davie, Vice President & General Manager of Clinical Development Services - Europe at Covance will give a presentation entitled “The Service Provider Perspective: How are CROs Preparing for the Future of Clinical Outsourcing?” at GTCbio’s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA. [PR.com - July 18, 2008] GTCbio http://www.pr.com/press-release/95748 http://www.pr.com/press-release/91249 Brahm Goldstein Novo Nordisk speaking regarding a rational approach towards pediatric drug development in the pharmaceutical industry at GTCbio’s Global Clinical Trial Operations Conference on 9/25-26. [PR.com - June 20, 2008] GTCbio http://www.pr.com/press-release/91249 http://www.pr.com/press-release/91251 Charlene Dark, Dir. of Life Sciences at Clarkston Consulting will be present on expediting accuracy through electronic data capture at GTCbio’s Global Clinical Trial Operations Conference on Sept. 25-26 in San Diego. [PR.com - June 20, 2008] GTCbio http://www.pr.com/press-release/91251 http://www.pr.com/press-release/91252 Cosimo Spera from Decision View Co. will give a presentation entitled “Marrying Complex Mathematical Models with Highly Usable Software Solutions to Improve Trial Enrollment Performance” at GTCbio’s Global Clinical Trial Operations Conference. [PR.com - June 20, 2008] GTCbio http://www.pr.com/press-release/91252 http://www.pr.com/press-release/90751 Amrit Ray, Vice President of Bristol-Myers Squibb will give the keynote presentation at GTCbio’s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA. Dr. Ray will give a presentation entitled “The Next Generation of Pharmacovigilance - Clinical Trials and Drug Development in the New Era of Drug Safety. [PR.com - June 18, 2008] GTCbio http://www.pr.com/press-release/90751 http://www.pr.com/press-release/89905 Paul Watt, Vice President of Drug Discovery at Phylogica to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA. [PR.com - June 13, 2008] GTCbio http://www.pr.com/press-release/89905 http://www.pr.com/press-release/89907 Lino Gonzalez from Genentech to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA. [PR.com - June 13, 2008] GTCbio http://www.pr.com/press-release/89907 http://www.pr.com/press-release/89909 Kanji Takada, Group Leader of Experimental Therapeutics at Celgene to Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA. [PR.com - June 13, 2008] GTCbio http://www.pr.com/press-release/89909 http://www.pr.com/press-release/89911 David Szymkowski, Senior Director of Biotherapeutics at Xencor will Present at GTCbio’s 2nd Protein Therapeutics Discovery & Development Conference on September 8-9, 2008 in San Diego, CA [PR.com - June 13, 2008] GTCbio http://www.pr.com/press-release/89911 http://www.pr.com/press-release/89699 Dr. Keith James, Senior Vice President and Site Head of Pfizer La Jolla will present at the Plenary Keynote session at GTCbio’s 4th Modern Drug Discovery and Development Summit on October 15-17, 2008 at the Hilton La Jolla Torrey Pines in La Jolla, CA. Dr. James’ will speak on the challenges & opportunities of driving global R&D performance. His presentation will explore approaches taken at Pfizer to [PR.com - June 12, 2008] GTCbio http://www.pr.com/press-release/89699 http://www.pr.com/press-release/81489 Dr. Y. Gloria Meng, Senior Scientist of Technology at Genentech will give a presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Meng will speak on electrochemiluminescence to detect surface proteins on live cells. [PR.com - April 30, 2008] GTCbio http://www.pr.com/press-release/81489 http://www.pr.com/press-release/81213 Dr. Matthew Olson, Principle Research Scientist at Johnson & Johnson will give a presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Olsen will present on “Coupling Label-free and Flouormetric Functional Assays with Biophysical Binding Assays: A Comparison of Positives from an HTS Campaign.” HTS campaigns continue to push [PR.com - April 18, 2008] GTCbio http://www.pr.com/press-release/81213 http://www.pr.com/press-release/80017 Chris Austin, Director of the NIH Chemical Genomics Center to give Keynote Presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA Dr. Christopher P. Austin, Director of the NIH Chemical Genomics Center will give the Keynote Presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San [PR.com - April 10, 2008] GTCbio http://www.pr.com/press-release/80017 http://www.pr.com/press-release/79025 Dr. Hakim Djaballah, Director of High Throughput Screening Core Facility at the Memorial Sloan Kettering Cancer Center will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Djaballah will speak on successful applications of high content assays using confocal microscopy. Traditional screening has long been associated with a one to one [PR.com - April 03, 2008] GTCbio http://www.pr.com/press-release/79025 http://www.pr.com/press-release/79027 John Cuozzo, Director of ELT Lead Discovery at GlaxoSmithKline to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA Dr. John W. Cuozzo, Director of ELT Lead Discovery at GlaxoSmithKline will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Cuozzo will speak on [PR.com - April 03, 2008] GTCbio http://www.pr.com/press-release/79027 http://www.pr.com/press-release/79028 Dr. Xi Chen, Assistant Professor in the Department of Chemistry at the University of California, Davis will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. [PR.com - April 03, 2008] GTCbio http://www.pr.com/press-release/79028 http://www.pr.com/press-release/79029 Dr. Taosheng Chen, Director of HTS, St. Jude Children's Research Hospital will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Chen will speak on a chemical biology approach to identify modulators of xenobiotic receptor PXR. Pregnane X receptor (PXR) has been established as a key xenobiotic receptor regulating metabolism and excretion of [PR.com - April 03, 2008] GTCbio http://www.pr.com/press-release/79029 http://www.pr.com/press-release/79030 Dr. Clay Scott, Associate Director of the Lead Generation Department at AstraZeneca will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA. Dr. Clay will speak on experiences in lead generation focusing on cellular dielectric spectroscopy as a platform technology for GPCR screening. Cellular dielectric spectroscopy (CDS) is a relatively new [PR.com - April 03, 2008] GTCbio http://www.pr.com/press-release/79030 http://www.pr.com/press-release/78500 Dr. Susan Taylor, Professor of Pharmacology at UCSD, will be giving the Featured Presentation at GTCbio’s 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA. [PR.com - March 30, 2008] GTCbio http://www.pr.com/press-release/78500 http://www.pr.com/press-release/78501 Dr. Karim Dabbagh the Director of Pharmacology at Hoffmann-La Roche will present at GTCbio’s 3rd Protein Kinase in Drug Discovery Conference on May 5-6, 2008 in San Diego, CA. [PR.com - March 30, 2008] GTCbio http://www.pr.com/press-release/78501 http://www.pr.com/press-release/77513 Dr. Berta Strulovici, Vice President of Basic Research MRL, and Automated Biotechnology Head at Merck & Co. will give Keynote Presentation at GTCbio’s 4th Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. [PR.com - March 28, 2008] GTCbio http://www.pr.com/press-release/77513 http://www.pr.com/press-release/77511 Dr. Robert Hertzberg, Vice President of Screening & Compound Profiling at GlaxoSmithKline will give the Keynote Presentation at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Hertzberg will present on “High Throughput Screening: A Technology That’s Easy to Love and Easy to Hate.” [PR.com - March 28, 2008] GTCbio http://www.pr.com/press-release/77511 http://www.pr.com/press-release/77509 Dr. Jeremy Caldwell, Executive Director of Molecular and Cell Biology at the Genomics Institute of the Novartis Research Foundation will give the Featured Presentation at GTCbio’s 4th Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA. Dr. Caldwell will discuss broad functional profiling of molecular libraries against biological space. [PR.com - March 23, 2008] GTCbio http://www.pr.com/press-release/77509 http://www.pr.com/press-release/77508 GTCbio just announced its holding the annual Modern Drug Discovery and Development Summit taking place on October 15-17, 2008 in San Diego, CA. Now in its fourth year, the summit will once again provide a landscape and in-depth industry analysis streaming through different therapeutic and target areas and examining the current advancements and where we’re headed in the coming years. [PR.com - March 23, 2008] GTCbio http://www.pr.com/press-release/77508 http://www.pr.com/press-release/75492 Massachusetts Senator Richard T. Moore to give Keynote Presentation at GTCbio’s 4th International Conference on Stem Cell Research & Therapeutics on April 17-18, 2008 in Boston, MA [PR.com - March 08, 2008] GTCbio http://www.pr.com/press-release/75492 http://www.pr.com/press-release/69384 2005’s new trend of Big Pharma acquisitions of small companies developing monoclonal antibodies has sparked a renewed interest for investors in the anti-infectives space. Four leading expert Venture Capitalists will meet to discuss the various investment opportunities in infectious diseases at the 5th Anti-Infectives Partnering & Deal-Making Summit taking place on March 5-7 in Philadelphia, PA. This investor [PR.com - January 26, 2008] GTCbio http://www.pr.com/press-release/69384 http://www.pr.com/press-release/69386 Roderic Pettigrew, Director at the National Institute of Biomedical Imaging & Bioengineering, NIH will give the keynote presentation at GTCbio’s 3rd Imaging in Drug Development conference March 17-18, 2008 in San Diego, CA. Dr. Pettigrew will discuss the importance of imaging in 21st century healthcare and its essential involvement in many aspects of the drug discovery process. Dr. Pettigrew’s research at [PR.com - January 26, 2008] GTCbio http://www.pr.com/press-release/69386 http://www.pr.com/press-release/69387 Dr. Hisataka Kobayashi, Chief Scientist of Molecular Imaging at the National Cancer Institute will speak at GTCbio’s 3rd Imaging in Pre-clinical & Clinical Drug Development conference March 17-18, 2008 in San Diego, CA. Dr. Kobayashi will discuss environment sensitive "smart" imaging probe for super-specific cancer cell detection. A major goal of targeted molecular imaging of cancer is to improve the [PR.com - January 26, 2008] GTCbio http://www.pr.com/press-release/69387 http://www.pr.com/press-release/69388 GTCbio announces the 4th International Stem Cell Research & Therapeutics on April 17-18, 2008 in Boston, MA – featuring a keynote presentation from the Rudolf Jaenisch, a Founding Member of Whitehead Institute, a pioneer of transgenic science, and a leader in the field of therapeutic cloning, also called nuclear transfer. [PR.com - January 26, 2008] GTCbio http://www.pr.com/press-release/69388 http://www.pr.com/press-release/69389 Dr. Christophe Labie, Group Leader of the Molecular Neurobiology Group at Sanofi-Aventis will give a presentation entitled “Stimulation of Brain Neurogenesis: A Way to Replace Neuron Loss in Diseased or Injured Brain” at GTCbio’s 4th Stem Cell Research & Therapeutics on April 17-18, 2008 in Boston, MA. Regeneration-based therapy is an emerging area in modern medicine, as is evidenced by numerous [PR.com - January 24, 2008] GTCbio http://www.pr.com/press-release/69389